CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | ELDRED KARY Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | AMELIO GILBERT F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | CALLICUTT JACK W Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-01-26 | Boudes Pol F Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-01-26 | LEWIS JOEL President and CEO | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2023-01-26 | CZIRR JAMES C Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | Uihlein Richard E Director | Grant or award | +36,036 | $1.11 | $40K | 7,999,291 |
| 2023-01-26 | Uihlein Richard E Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-25 | ELDRED KARY Director | Purchase | +1,300 | $1.11 | $1K | 46,215 |
| 2023-01-13 | LEWIS JOEL President and CEO | Grant or award | +15,351 | $1.14 | $18K | 714,218 |
| 2022-12-30 | LEWIS JOEL President and CEO | Grant or award | +15,487 | $1.13 | $18K | 698,867 |
| 2022-12-15 | LEWIS JOEL President and CEO | Grant or award | +15,086 | $1.16 | $17K | 683,380 |
| 2022-11-30 | LEWIS JOEL President and CEO | Grant or award | +13,780 | $1.27 | $18K | 668,294 |
| 2022-11-17 | CALLICUTT JACK W Chief Financial Officer | Purchase | +4,000 | $1.32 | $5K | 7,614 |
| 2022-11-15 | LEWIS JOEL President and CEO | Grant or award | +14,113 | $1.24 | $18K | 654,514 |
| 2022-10-31 | LEWIS JOEL President and CEO | Grant or award | +12,681 | $1.38 | $17K | 640,401 |
| 2022-10-28 | FREEMAN KEVIN D Director | Purchase | +10,000 | $1.41 | $14K | 75,000 |
| 2022-10-14 | LEWIS JOEL President and CEO | Grant or award | +10,802 | $1.62 | $17K | 627,720 |
| 2022-09-30 | LEWIS JOEL President and CEO | Grant or award | +10,736 | $1.63 | $17K | 616,918 |
| 2022-09-30 | LEWIS JOEL President and CEO | Grant or award | +10,736 | $1.79 | $19K | 616,918 |
Page 18 of 21 · 404 trades